Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
The initiative pairs consumer engagement with a public health message about prevention and early detection
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
Subscribe To Our Newsletter & Stay Updated
